Thiotepa-Busulfan-Fludarabine Compared to Treosulfan-Based Conditioning for Haploidentical Transplant with Posttransplant Cyclophosphamide in Patients with Acute Myeloid Leukemia in Remission: A Study from the Acute Leukemia Working Party of the EBMT

Investigators conducted a registry analysis including adult acute myeloid leukemia (AML) patients in remission who had received thiotepa, busulfan, and fludarabine or treosulfan-basedconditioning for haplo-hematopoietic stem cell transplant with posttransplant cyclophosphamide between 2010 and 2020.